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Complement component C9 undergoes a major conformational change during its insertion i to a biological membrane 
from a globular to an extended form. At 0°C a single C9 binds but a membrane attack complex (MAC) is not formed. 
We show that the C9 bound at 0°C is accessible to the intraeellular space and sensitive to trypsin digestion, suggesting 
that C9 inserts in its globular state and requires an elevated temperature in order to change conformation. 
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1. INTRODUCTION 
The insertion of complement component C9 into 
a biological membrane depends on the prior for- 
mation in the membrane of a stoichiometric C5b- 
C6-C7-C8 complex (C5b-8). One or more C9 
molecules are able to bind to this receptor and in- 
sert into the bilayer to form a stable pore. During 
C9 insertion the molecule undergoes a rearrange- 
ment from an aqueous, globular protein into an 
elongated molecule of about twice the length with 
the properties of an integral membrane protein 
(review [1]). Understanding this process could be 
of importance for the post-translational insertion 
of other membrane proteins as well as complement 
action, yet few of the steps have been described in 
molecular detail. 
Studies by Boyle et al. [2] showed that a single 
C9 molecule could bind to C5b-8 at 0°C and that 
trypsin digestion of this complex at 0°C could pre- 
vent subsequent MAC formation on warming to 
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37°C. If the complex assembled at 0°C was 
warmed to 37°C, even for short times, before 
digestion with trypsin the sensitivity of MAC for- 
mation to proteolysis was lost. This result was in- 
terpreted as being due to initial binding of globular 
C9 to an extracellular binding site on C5b-8 
followed by shielding of  the C9 with lipids after 
elevating the temperature to 37°C. We have now 
used a monoclonal antibody to C9 to show that the 
trypsin-sensitive C9 is accessible to intracellular 
antibodies, suggesting that globular C9 is inserted 
deep into the lipid bilayer and that the 
temperature-dependent stepin MAC formation is 
the transition from globular to extended C9. 
2. EXPERIMENTAL 
2.1. lodination of C9 
10/4g human (29, purified by the method of Morgan et al. [3], 
was labelled with 0.5 mCi 125I by the Iodogen method [4] giving 
an incorporation of 0.6 atoms per molecule. 
2.2. Immunoprecipitation f C9 
Mouse monoclonal ntibodies (2/~g IgG) were added to 125I- 
labelled C9 (5 ng, 100000 cpm) in 500/~1 PBS containing 1% 
Triton X-100, 0.1% SDS, 0.1% deoxycholate nd 0.1% bovine 
serum albumin (RIPA buffer). Mouse IgG was then adsorbed 
onto sheep anti-(mouse Ig) immunoadsorbant at 0°C overnight 
and after 2 washes in RIPA buffer, 1 wash in RIPA buffer con- 
taining 0.5 M NaCI and 2 washes in 10 mM Tris-HCl (pH 7.4), 
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the immunoprecipitates were dissolved in sample buffer con- 
taining 4070 SDS. After boiling for 5 rain the samples were elec- 
trophoresed on 12.5°70 polyacrylamide g ls which were dried 
and autoradiographed. 
2.3. Erythrocyte ghost experiments 
Rabbit erythrocyte ghosts, with or without entrapped 
monoclonal antibodies, were prepared from 100-/zl aliquots of 
packed erythrocytes as previously de cribed for pigeon 
erythrocytes, but with 7 final washes [5,6]. Ghosts were coated 
with C5b-8 by incubation for 5 rain at 37°C with C9-depleted 
human serum diluted 1 : 5 in PBS. The ghosts were washed twice 
with medium A (140 mM NaCl, 5 mM KC1, 2 mM MgCI2 and 
10 mM Tes, pH 7.4) and resuspended in 100/zl of the same 
medium at 0°C. 125I-labelled C9 (5 ng, 100000 cpm) was added 
for 2 rain at 0°C and after washing twice with coldmedium A, 
the ghosts were incubated in 100/~l medium A for a further 
5 min at 0 or 37°C. The ghosts were again washed twice with 
cold medium A, resuspended in 100/A of the same medium and 
incubated for 1 h at 0°C with trypsin (0.5 mg/ml). Soybean 
trypsin inhibitor (0.5 mg/ml) and PMSF (40/~g/ml) were added 
for 5 rain at 0°C and after 2 further washes ghosts were lysed 
in 500/~l RIPA buffer and used for immunoprecipitation as 
described above. 
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3. RESULTS 
M34 and M36 are two monoclonal  antibodies 
raised against globular C9 which have a similar 
dissociation constant [3], but which show a dif- 
ferent inhibition of  ~4C-labelled sucrose efflux 
f rom erythrocyte ghosts. M36 inhibits efflux when 
added externally, but M34 only inhibits efflux 
when included with the label inside the ghosts [5]. 
Fig. 1 shows that monoclonal  M36 has a similar 
epitope to M34 by Western blot o f  trypsin 
fragments o f  C9. Both antibodies were able to bind 
to identical fragments, indicating that their 
epitopes are located within the same proteolytically 
stable domains. The first trypsin cleavage occurs 
between residues 391 and 392 of  human C9 [7], 
giving rise to an amino-terminal fragment o f  ap- 
prox. 48 kDa in unreduced gels which is positive 
with both antibodies (lanes 5,8). The 21 kDa frag- 
ment released by trypsin digestion from the 
carboxy-terminus i not detected by either an- 
t ibody. Further digestion with trypsin results in a 
second cleavage in the centre o f  the molecule close 
to the cr-thrombin cleavage site. The fragment 
released by this cleavage (approx. 30 kDa on 
unreduced gels) is also positive (fig.l, lanes 6,9) 
showing that both M34 and M36 bind to the 
amino-terminal (C9a) half o f  the molecule. 
M34 and M36 were also checked for their ability 
Fig. 1. M34 and M36 have epitopes in the amino-terminal half 
of C9. Purified human complement component C9 was digested 
with TPCK-treated trypsin and run on a 10-15070 non-reducing 
polyacrylamide gel. Lanes: (1-3) Serva brilliant blue stain; 
(4-6) monoclonal M34 immunoblot; (7-9) monoclonal M36 
immunoblot. Lanes: (1,4,7) 2/~g undigested C9; (2,5,8) 2/~g C9 
incubated with 100 ng trypsin for 30 rain at 25°C; (3,6,9) 2/~g 
C9 incubated with 500 ng trypsin for 30 min at 25°C. 
to immunoprecipitate C9. Fig.2a shows that the 
recovery o f  labelled C9 was similar using both M34 
and M36, but that after trypsin digestion of  the C9 
for 60min  at 0°C little immunoprecipitable 
material remains. 
M36 was then entrapped in ghosts and 125I- 
labelled C9 bound at 0°C as described in section 2. 
Cells were either maintained at 0°C (fig.2b, lane 1) 
or warmed to 37°C (fig.2b, lane 2) for 5 min and 
then cooled and digested with trypsin for 60 min at 
0°C. It can be seen that raising the temperature to 
37°C for 5 min renders the C9 insensitive to tryp- 
sin, thus increasing its recovery in the im- 
munoprecipitation. When this experiment was 
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Fig.2. M34 but not M36 is able to prevent the molecular 
rearrangement of C9 by binding to C9 from the cytoplasmic 
compartment during insertion. (a) Control immunoprecipita- 
tion of 5 ng human C9 by 2/~g monoclonal antibodies M34 
(lanes 1,3) and M36 (lanes 2,4). Lanes: (1,2) before dig stion of 
C9; (3,4) after digestion with 0.5 mg/ml trypsin for 60 min at 
0°C. (b) Immunoprecipitation of C9 in rabbit erythrocyte 
ghosts as described in section 2 with (lanes 2,4) or without (lanes 
1,3) an incubation for 5 rain at 37°C before trypsin digestion at 
0°C. Lanes 1,2, intracellular M36; ,4, intraceUular M34. 
repeated with M34 no protection of the C9 against 
trypsin digestion was observed (fig.2b, lanes 3,4). 
This antibody is therefore able to prevent he tran- 
sition in C9 which normally renders it trypsin in- 
sensitive after warming to 37°C. Only 
membrane-bound C9 can be present in im- 
munoprecipitates, ince the ghosts are washed 
before solubilization of the ghosts can release the 
antibody and also because the concentration of 
trypsin used would have completely degraded the 
extracellular C9 (fig.2a). 
4. DISCUSSION 
Morgan et al. [5] showed that one monoclonal 
antibody raised against C9 (M34) had the in- 
teresting property of being able to inhibit the ef- 
flux of 14C-labelled sucrose when induced with the 
label inside erythrocyte ghosts, but not when add- 
ed extracellularly. M34 was subsequently shown to 
bind to the amino-terminal portion of C9 after 
cleavage with trypsin or a,-thrombin [7], but does 
not react with reduced protein fragments or short 
segments of polypeptide xpressed in E. coli (not 
shown), suggesting a discontinuous epitope involv- 
ing cysteine-rich regions within the amino-terminal 
half of C9. Taken together, these two results im- 
plied that the amino-terminal portion of C9 is tran- 
siently exposed to the cytoplasmic space during 
insertion into the membrane [8]. One molecular in- 
terpretation of this conclusion is that C9 inserts in- 
to the membrane in its globular conformation and 
only in a second step refolds into a membrane- 
interacting emended conformation [1,8]. We have 
tested this model by investigating whether the C9 
which is capable of interacting with M34 from the 
intracellular space is trypsin sensitive, a 
characteristic of globular C9. 
The experiments hat we have presented confirm 
the original observation by Boyle et al. [2] that C9 
bound at 0°C undergoes a transition on raising the 
temperature to 37°C that renders it resistant o 
trypsin digestion. We also find that this transition 
may be prevented by intracellular monoclonal an- 
tibody M34 showing that: (i) the epitope of M34 on 
the amino-terminal half of C9 has access to the in- 
tracellular compartment during insertion into 
erythrocytes; (ii) C9 inserts into the membrane in 
its trypsin-sensitive conformation; and (iii) M34 
locks C9 in its globular conformation preventing 
the transition to a trypsin-resistant form. 
The earlier terminal components C7, C8te and 
C8~ have all been shown to have a C9-1ike se- 
quence [9] which allows a change from globular to 
extended forms on insertion into the membrane 
[10]. Even a single C9 molecule could therefore be 
stabilised in its extended form when C5b-9 is 
raised from 0 to 37°C, giving a proteolytically 
stable protein complex. Such complexes have also 
been shown to make stable channels of a size sug- 
gesting the contribution of components other than 
C9 to the transmembrane pore [11]. Thus, the 
transition from trypsin-sensitive to -insensitive C9 
in these experiments i  most likely to represent the 
conformational rearrangement of C9 from 
globular C9 bound to C5b-8 to its extended con- 
formation. From the present data, this transition 
occurs after insertion into the membrane and re- 
quires an elevated temperature. 
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